These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 22185135)

  • 21. Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants.
    Yukawa E; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2005 Apr; 30(2):159-63. PubMed ID: 15811169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenobarbital-induced alterations in vitamin D metabolism.
    Hahn TJ; Birge SJ; Scharp CR; Avioli LV
    J Clin Invest; 1972 Apr; 51(4):741-8. PubMed ID: 4335442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
    Pershing LK; Franklin MR
    Xenobiotica; 1982 Nov; 12(11):687-99. PubMed ID: 6984805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of the development of tolerance to nitrazepam and phenobarbital under experimental conditions].
    Klygul' TA
    Farmakol Toksikol; 1976; 39(5):532-7. PubMed ID: 1028578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity.
    Elrick MM; Kramer JA; Alden CL; Blomme EA; Bunch RT; Cabonce MA; Curtiss SW; Kier LD; Kolaja KL; Rodi CP; Morris DL
    Toxicol Pathol; 2005; 33(1):118-26. PubMed ID: 15805063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms of detecting organic cholephilic anions in man: comparative studies on plasma depuration of rifamycin-SV. Interference of nicotinic acid and phenobarbital].
    Gentile S; Porcellini M; Foglia F; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1307-11. PubMed ID: 508427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic phenobarbital on verapamil disposition in humans.
    Rutledge DR; Pieper JA; Mirvis DM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between the phase of the sex cycle and differences in the rate of hexenal detoxication and its induction by phenobarbital in female rats].
    Rozanova VD
    Farmakol Toksikol; 1979; 42(1):29-33. PubMed ID: 570513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of the anticonvulsants phenobarbital and diphenylhydantoin on intestinal absorption of calcium.
    Foss MC; Meneghelli UG; Tabosa Veríssimo JM
    Acta Physiol Lat Am; 1979; 29(4-5):223-8. PubMed ID: 263172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The correction of the liver detoxifying function with phenobarbital and ziksorin before and after ischemia].
    Grek OR; Rybakova TA; Sharapov VI; Zakharova MV; Shkurupiĭ VA
    Eksp Klin Farmakol; 1993; 56(5):30-3. PubMed ID: 8312805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differences in the inductive effect of small doses of phenobarbital in rats depending on their age and sex].
    Rozanova VD; Surovtseva ZF; Siryk LA
    Farmakol Toksikol; 1978; 41(1):40-4. PubMed ID: 624388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic kinetics of L-tryptophan under the effect of phenobarbital in the child].
    Schmidt H; Tolckmitt W
    Int J Clin Pharmacol; 1973 Aug; 8(1):15-21. PubMed ID: 4727444
    [No Abstract]   [Full Text] [Related]  

  • 36. [Differential induction of some microsomal metabolic reactions of progesterone by treatment of rabbits with phenobarbital].
    Lange G; Thun KJ
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):266-7. PubMed ID: 4242412
    [No Abstract]   [Full Text] [Related]  

  • 37. Accuracy of five methods for predicting phenobarbital concentrations in pediatric patients.
    Beck DE; Ravis WR; Snead OC
    Clin Pharm; 1986 Sep; 5(9):754-9. PubMed ID: 3757446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Directed microbial biosynthesis of deuterated biosurfactants and potential future application to other bioactive molecules.
    Smyth TJ; Perfumo A; Marchant R; Banat IM; Chen M; Thomas RK; Penfold J; Stevenson PS; Parry NJ
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1347-54. PubMed ID: 20405122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response.
    Konstandi M; Segos D; Galanopoulou P; Theocharis S; Zarros A; Lang MA; Marselos M; Liapi C
    J Appl Toxicol; 2009 Mar; 29(2):101-9. PubMed ID: 18798224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphological study of the hepatocyte in cirrhotic patients treated with phenobarbital].
    Jiménez Cardoso JM; Herrera E; Alcántara G; Martín L; Wusterhaus AH
    Rev Gastroenterol Mex; 1975; 40(2):71-5. PubMed ID: 1236193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.